A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of...

por Chue, P., Silverstone, P., Hillier, T., Rizvi, S., Phillips, S., Langkaas, L.-A., Davidson, K., Brown, M., Chue, J.
Publicado 2023